Sterile blood separating system

Information

  • Patent Grant
  • 8518272
  • Patent Number
    8,518,272
  • Date Filed
    Friday, April 4, 2008
    16 years ago
  • Date Issued
    Tuesday, August 27, 2013
    11 years ago
Abstract
A system for separating components of a composition according to density. The system includes a torque generating device, a separation device, and a housing. The separation device separates the composition into different components according to density. The housing accommodates the separation device. The housing includes a base having an interface that transfers torque from the torque generating device to the separation device, a cover, and a conduit for introducing the composition into the separation device without opening the cover.
Description
FIELD

The present disclosure relates to sterile devices, systems, and methods for separating components of a composition, such as blood.


BACKGROUND

The statements in this section merely provide background information related to the present disclosure and may not constitute prior art.


Whole blood includes a variety of different fractions or parts. For example, human whole blood includes platelet rich plasma (PRP), platelet poor plasma (PPP), red blood cells (RBCs), and white blood cells (WBCs). These different blood fractions have a variety of clinical and experimental uses. There is a need for devices and methods that separate and isolate the different fractions of whole blood. In particular, there is a need for devices and methods for separating and isolating different blood fractions in a non-sterile environment by non-sterile personnel for later use in a sterile environment.


SUMMARY

The present teachings provide for a system for separating components of a composition according to density. The system includes a torque generating device, a separation device, and a housing. The separation device separates the composition into different components according to density. The housing accommodates the separation device. The housing includes a base having an interface that transfers torque from the torque generating device to the separation device, a cover, and a conduit for introducing the composition into the separation device without opening the cover.


The present teachings further provide for a method for separating components of a composition according to density. The method includes: sealing a sterilized separation device within a container having a base and a cover such that the separation device is in cooperation with an interface at the base of the container; inserting the composition into the sterilized separation device sealed within the container by injecting the composition through a conduit that extends through the container and mates with the separation device; mating the container with a torque generating device, the interface in contact with both the torque generating device and the separation device; spinning the separation device using the torque generating device to separate the composition into different components according to density, the separation device is spun independent of the container and torque is transferred from the torque generating device to the separation device by the interface; removing the sterile separation device from the container; and withdrawing at least one of the different components from the separation device as necessary while the separation device is in the sterile environment.


The present teachings also provide for a container for housing a sterile separation device for separating components of a composition according to density. The container includes a container base, an interface, a cover, and a conduit. The container base has sidewalls extending from the container base to define a receptacle for accommodating the separation device. The interface is at the container base for transferring torque from a torque generating device to the separation device when the separation device is seated within the receptacle. The cover covers the receptacle and seals the sterile separation device within the receptacle to prevent contamination of the sterile separation device. The conduit extends through the container to the sterile separation device to permit delivery of blood through the container and into the sterile separation device when the sterile separation device is sealed within the receptacle.


Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.





DRAWINGS

The drawings described herein are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way.



FIG. 1 is a perspective view of a system for separating components of blood according to the present teachings;



FIG. 2 is an exploded side view of the system of FIG. 1;



FIG. 3 is an assembled cross-sectional side view of the system of FIG. 1; and



FIG. 4 is a cross-sectional side view of another system for separating blood components according to the present teachings.





DETAILED DESCRIPTION

The following description is merely exemplary in nature and is not intended to limit the present disclosure, application, or uses.


A system for separating components of a composition according to density is illustrated in FIGS. 1-3 at reference numeral 10. The system generally includes a component separation device 12, a container 14 for accommodating the separation device 12, a cover 16, and a motorized rotating platform 18. The system 10 can be used to separate components of a variety of compositions, such as whole blood as described herein.


The separation device 12 includes a main body 20 that defines a separation chamber 22. The main body 20 includes a first end 24, a second end 26, and a cylindrical sidewall 27 that extends between the first end 24 and the second end 26. The main body 20 is sized to fit within the container 14. While the separation device 12 described herein is merely an exemplary device, the device 12 is based off the separation devices of Biomet Inc.'s GPS system as described in, for example, U.S. Pat. No. 7,179,391 (filed May 23, 2003) and U.S. Publication Nos. 2005-0109716 (filed Sep. 2, 2004) and 2006-0273049 (filed May 25, 2006), which are hereby incorporated by reference. Differences between the device 12 and the separation tubes of the GPS devices include the location of the outlet ports 32 and 34 at the sidewall 27 and the presence of the locking details 48. In addition to the separation devices of the GPS, any suitable separation device can be used after being modified to include the locking details 48 and the outlet ports 32 and 34.


At the sidewall 27 is a first inlet port 28 and a second inlet port 30. The first and the second inlet ports 28 and 30 extend through the sidewall 27 to permit the introduction of materials into the separation chamber 22. As illustrated, the first and the second inlet ports 28 and 30 extend from the sidewall 27. However, the first and the second inlet ports 28 and 30 can be recesses in the sidewall 27 or can be co-planar with the sidewall 27, for example.


Also at the sidewall 27 is a first outlet port 32 and a second outlet port 34. The first and the second outlet ports 32 and 34 extend through the sidewall 27 to permit withdrawal of materials from within the separation chamber 22. As illustrated, the first and the second outlet ports 32/34 each extend from the sidewall 27 and are each covered with a removable cap. The first outlet port 32 includes a first outlet tube 36 and the second outlet port 34 includes a second outlet tube 38 that extends to within the separation chamber 22. The first outlet tube 36 and the second outlet tube 38 can each be directed to different areas of the separation chamber 22 to facilitate withdrawal of components at different regions of the separation chamber 22.


The separation device 12 can be configured to separate components of various different materials or substances by density. For example, the separation device 12 can be a blood component separation device to separate various components of whole blood by density, such as platelet rich plasma, red blood cells, platelets, and white blood cells. The separation device 12 is illustrated as an exemplary blood component separation device.


For example, as a blood component separation device the device 12 includes a separator (which includes a buoy 40 and a divider 44) and a counter-balance 41 at an end of the separation chamber 22 opposite to the buoy 40. The buoy 40 has a shape that conforms to the interior shape of the separation chamber 22. The buoy 40 has a tuned density that is configured to reach a selected equilibrium position in blood. For example, the buoy 40 can have a density tuned in the range from about 1.06 g/cc to about 1.11 g/cc, which is less than the density of red blood cells of whole blood. The buoy 40 has an access port 42 that extends through the buoy 40. The first outlet tube 36 of the first outlet port 32 is connected to the access port 42 of the buoy 40


Mounted to the buoy 40 is the divider 44. The divider 44 is mounted to an end of the buoy 40 opposite to an end where the first outlet tube 36 enters the buoy 40. The divider 44 is mounted to the buoy 40 to create a collection compartment 46 between the divider 44 and the buoy 40. Components present within the collection compartment 46 can be withdrawn from within the separation chamber 22 through the access port 42, which extends to the collection compartment 46 and is in communication with both the first outlet tube 36 and the first outlet port 32


The buoy 40 is movable within the separation chamber 22 laterally with respect to the first end 24 and the second end 26. When the separation device 12 is at rest, the buoy 40 forms an interference fit with the separation chamber 22 to hold the buoy at a position in the separation chamber 22. When the device 12 is rotated upon the platform 18, buoy 40 moves until it reaches an equilibrium within the composition being separated, such as whole blood. Material present in the separation chamber 22, such as blood, is able to pass between the buoy 40, as well as the divider 44, and the inner walls of the separation chamber 22. Alternatively, the buoy 40 and the divider 44 can have an opening to allow material to move through the buoy 40 and the divider 44.


The sidewall 27 of the main body 20 further includes one or more locking details 48 that are located opposite to the outlet ports 32 and 34. As illustrated, the locking details 48 protrude from sidewall 27. However, the locking details 48 can be of any shape, size, or configuration to provide cooperation with the container 14 and the rotating platform 18 to transfer torque from the platform 18 to the separation device 12.


The container 14 includes a container base 50 and cylindrical container sidewalls 52 that extend around the base 50. The base 50 and the sidewalls 52 define a receptacle sized to receive the separation device 12. The base 50 includes an interface 54. The interface 54 cooperates with the rotating platform 18 and receives the separation device 12 to transfer torque from the rotating platform 18 to the separation device 12. Between the interface 54 and the container 14 is a bushing to allow the interface 54 to rotate independent of the container 14. In particular, the interface 54 includes one or more receptacles 56 at a first end and a bottom portion 58 at a second end that is opposite to the receptacles 56. The receptacles 56 receive the locking details 48 of the separation device 12. The bottom portion 58 cooperates with the platform 18 to transfer torque from the platform 18 to the separation device 12.


The rotating platform 18 can be any suitable torque generating device. For example, the rotating platform 18 can be a Vortech type base by Biomet Biologics, Inc. of Warsaw, Ind.


The cover 16 includes an upper portion 60 and a lower portion 62. Side portions 64 extend between the upper portion 60 and the lower portion 62. A first conduit 66 and a second conduit 68 both extend through the cover 16. The first conduit 66 can include a first cap 70 and the second conduit 68 can include a second cap 72. As illustrated in FIG. 2, when the separation device 12 is seated in the container 14 and the cover 16 is on the container 14, the first conduit 66 is aligned with and connected to the first inlet port 28 and the second conduit 68 is aligned with and connected to the second inlet port 30. The connections between the conduits 66/72 and the ports 28/30 provide passages through the cover 16 to permit the introduction of blood, for example, through the cover 16 and into the separation device 12 when the cover 16 is in place over the device 12. The cover 16 can be independent of the container 14 or mounted to the container 14, such as with a hinge.


As illustrated in FIG. 3, the sidewalls 52 of the container 14 include locking details 74 at the ends of the sidewalls that are opposite to the container base 50. The locking details 74 of the container 14 cooperate with locking details 76 of the cover 16. Thus, the cover 16 is mounted to the container 14. To permit the separation device 12 to freely rotate within the container 14 when the cover 16 is in place, the conduits 66 and 68 are slidably removed to detach the cover 16 from the separation device 12, but not completely removed from the cover 16. In this regard, the passageway through the cover 16 that the conduits 66 and 68 are seated in remains filled so as to restrict the passage of bacteria and non-sterile materials through the cover 16. The cover 16 can also be mounted to the container 14 with a hinge at the sidewalls 52.


With reference to FIG. 4, the system 10 can alternatively be provided with a cover 16 that is directly attached to the separation device 12. As a result, the cover 16 can rotate with the separation device 12 and the first and second conduits 66 and 68 do not need to be detached from the separation device 12 to permit rotation of the separation device 12. A bushing is provided between the cover 16 and the walls 52 of the container to reduce friction and allow the cover 16 to freely rotate within the container 14.


In use, the device 12, the container 14, and the cover 16 are sterilized. The sterile separation device 12 is placed in the sterile container and the sterile cover 16 is seated over the separation device 12 to prevent contamination of the separation device 12. With the separation device 12 sealed within the container 14, the container 14 can be handled by non-sterile personnel. For example, non-sterile personnel can transport the separation device 12 and/or load the separation device 12 with a composition to be separated, such as blood. For example, blood can be inserted into the separation device 12 through the first and/or second ports 28 and 30 using the first and/or second conduits 66 and 68.


After the separation device 12 is filled with blood, the container 14 is seated on the rotating platform 18. The separation device 12 is spun by the platform 18 for a suitable time at a suitable speed to generate a force of about 593×g. After the device 12 is spun as appropriate, the different components of blood will be separated according to density. For example, red blood cells typically settle between the divider 44 and the second end 26, a buffy coat of white blood cells and blood platelets typically settles in the collection compartment 46 between the buoy 40 and the divider 44, and platelet poor plasma typically settles between the counterbalance 41 and the buoy 40.


The sterile container 12 can then be opened and the separation device 12 can be removed by sterile personnel in the sterile environment or simply dumped into the sterile environment, such as onto a sterile tray. The desired blood fraction can be extracted through the first and/or the second outlet ports 32 and 34. For example, if blood platelets are desired to be extracted they can be extracted using the first outlet port 32 because the first outlet port 32, via the first outlet tube 36, extends to the collection compartment 46 where the platelets settle. Using the first outlet port 32, the red blood cells can be subsequently extracted after extraction of the platelets as the red blood cells can be withdrawn through and/or past the divider 44. If the platelet poor plasma is to be extracted, the second outlet port 34 can be used because the second outlet tube 38 extends to the region where the platelet poor plasma typically settles.


Thus, when sealed within the container 14, the sterile separation device 12 can be filled and spun by non-sterile personnel in a non-sterile environment. The container 14 can then be opened and the sterile separation device 12 can be removed and transferred to the sterile environment where the separated components can be withdrawn from the device 12 as necessary. Thus, while in the container 14 the sterility of the device 12 can be maintained even though the device is in a non-sterile environment, which offers greater flexibility for use and transport of the device 12.


The description of the invention is merely exemplary in nature and, thus, variations that do not depart from the gist of the invention are intended to be within the scope of the invention. Such variations are not to be regarded as a departure from the spirit and scope of the invention.

Claims
  • 1. A system for separating components of a composition according to density comprising: a torque generating device;a separation device for separating the composition into different components according to density, the separation device including: a first end and a second end opposite to the first end, wherein a longitudinal axis extends between the first end and the second end;a sidewall extending between the first end and the second end, the sidewall defining a separation chamber;a separator within the separation chamber along the longitudinal axis;an inlet port and an outlet port each extending through the sidewall between the first end and the second end; anda counterbalance between the second end and the inlet port; anda housing that accommodates the separation device to maintain the separation device in a sterile condition when seated therein;wherein the torque generating device is external to the housing and is configured to supply torque to the separation device when seated in the housing.
  • 2. The system of claim 1, wherein the torque generating device includes a motorized rotating platform.
  • 3. The system of claim 1, wherein the separator includes a buoy slidable along the longitudinal axis having a density less than that of red blood cells of whole blood.
  • 4. A separation device for separating components of a composition according to density comprising: a first end, a second end, a sidewall that extends between the first end and the second end to define a separation chamber, wherein a longitudinal axis extends through the separation chamber between the first end and the second end;a separator slidably mounted within the separation chamber along the longitudinal axis and having a density such that the separator is operable to move to an equilibrium between two of the components to be separated after the separation device is rotated;a first outlet port including a first outlet tube that extends from a first side of the sidewall and through the buoy to provide fluid communication between an exterior of the separation device and a first area of the separation chamber between the separator and the second end;a second outlet port including a second outlet tube that extends from the first side of the sidewall to a second area of the separation chamber that is between the first end and the buoy separator; anda coupling device at a second side of the sidewall that is opposite to the first side of the sidewall surface, the coupling device is configured to receive torque generated by a torque generating device;wherein upon rotation of the separation device about a midpoint between the first end and the second end along the longitudinal axis in a plane that is perpendicular to a longitudinal axis along which the torque is applied, the separator is operable to separate a first component of the composition having a first density from a second component of the composition having a second density, the first component is isolated in the first area of the separation chamber and the second component is isolated in the second area of the separation chamber.
  • 5. The separation device of claim 4, further comprising an inlet port that provides fluid communication with an interior of the separation device, the inlet port is at the first side of the sidewall and spaced apart from the first and second outlet ports.
  • 6. The separation device of claim 4, wherein a first distance between the first end and the second end is greater than a second distance between the first side of the sidewall and the second side of the sidewall.
  • 7. The separation device of claim 4, wherein the separator further includes a buoy and a divider that is spaced apart from the buoy and mounted to the buoy to define a collection compartment between the divider and the buoy; wherein the first outlet tube extends across the collection compartment to the divider.
  • 8. A device for separating components of a composition according to density comprising: a separation device including: a first end, a second end opposite to the first end, a cylindrical sidewall extending between the first end and the second end to define a separation chamber, and a longitudinal axis extending through an axial center of the separation chamber from the first end to the second end;a counter-balance within the separation chamber and proximate to the first end;a separator including a buoy within the separation chamber and slidably mounted along the longitudinal axis between the second end and the counter-balance;a divider mounted to the buoy at a side of the buoy proximate to the second end, the buoy has a density such that it is operable to move to an equilibrium between two of the components to be separated;a first outlet port including a first outlet tube that extends from a first side of the sidewall to the divider, the first outlet tube extends through the buoy;a second outlet port including a second outlet tube that extends from the first side of the sidewall to a location within the separation chamber that is between the counter-balance and the buoy;an inlet port that provides fluid communication between an exterior of the separation device and the separation chamber, the inlet port is at the first side of the sidewall and spaced apart from the first and second outlet ports; anda locking device at a second side of the sidewall that is opposite to the first side and is operable to cooperate with a rotating platform to rotate the separation device; andan outer housing including a base and a sidewall that define a receptacle that accommodates the separation device and includes an interface operable to transfer torque from the rotating platform to the separation device when the separation device is seated in the receptacle;a cover configured to engage the outer housing to provide a seal therebetween and maintain the separation device in a sterile condition when seated within the receptacle, the cover includes a conduit extending therethrough, the conduit is operable to cooperate with the inlet port when the separation device is seated in the receptacle to permit introduction of the composition through the cover and into the separation device through the inlet port while the separation device is maintained in a sterile condition;wherein the rotating platform is external to the outer housing and is selectively coupled to the outer housing at the interface to supply torque to the separation device; andwherein upon rotation of the separation device by the rotating platform about a midpoint between the first end and the second end along the longitudinal axis in a plane that is perpendicular to a longitudinal axis along which the torque is applied and restricting rotation of the separation device about the longitudinal axis, the separator is operable to separate a first component of the composition having a first density from a second component of the composition having a second density, the first component is separated in a first area of the separation chamber between the divider and the first end and the second component is separated in a second area of the separation chamber between the divider and the second end.
  • 9. The system of claim 1, wherein the sidewall is cylindrical and the longitudinal axis extends through an axial center of the separation chamber.
  • 10. The system of claim 1, wherein the sidewall includes a locking device that is at a first portion of the sidewall opposite to a second portion of the sidewall including the inlet port and the outlet port, the locking device is configured to engage an interface at a base of the housing that transfers torque from the torque generating device to the housing.
  • 11. The system of claim 1, wherein the housing further comprises: a base;a cover configured to selectively engage one of the separation device or the housing to provide a seal therebetween that maintains the separation device in a sterile condition when seated in the housing; anda conduit extending through the cover and in communication with the inlet port for introducing the composition into the separation device without opening the cover to maintain the separation device in a sterile condition as the composition is introduced;wherein the torque generating device is external to the housing and selectively coupled to the housing at the base.
  • 12. The system of claim 11, wherein the cover is mounted directly to the separation device and rotates with the separation device.
  • 13. The system of claim 11, wherein the cover is mounted directly to the housing and is stationary when the separation device is rotating.
  • 14. The system of claim 11, wherein the conduit is movable to selectively engage and disengage the separation device without removing the cover.
  • 15. A system for separating components of a composition according to density comprising: A separation device including: A first end and a second end opposite to the first end, wherein a first longitudinal axis extends between the first end and the second end;A sidewall extending between the first end and the second end, the sidewall defining a separation chamber;A movable buoy within the separation chamber for separating components of the composition according to density; andAn inlet port and an outlet port each extending through the sidewall between the first end and the second end;A housing including a base, a housing sidewall extending from the base, and a cover, the housing defines a compartment configured to receive the separation device therein such that the first longitudinal axis is substantially parallel to the base, and maintain the separation device in a sterile condition; andA torque generating device external to the housing and selectively coupled to the housing to transfer torque to the separation device when seated in the compartment to rotate the separation device about a midpoint between the first end and the second end along the first longitudinal axis in a plane that is both substantially perpendicular to a second longitudinal axis along which the torque is applied and substantially parallel to the base.
  • 16. The system of claim 15, wherein a first distance between the first end and the second end is greater than a second distance between opposing sides of the sidewall.
  • 17. The system of claim 15, wherein the sidewall is a cylindrical sidewall.
  • 18. The system of claim 15, wherein the movable buoy includes a buoy movable along the first longitudinal axis.
  • 19. The system of claim 15, further comprising a counterbalance within the separation chamber at the second end, the separator is closer to the first end than to the second end.
  • 20. The system of claim 15, further comprising a conduit extending through the cover and in communication with the inlet port for introducing the composition into the separation device without opening the cover to maintain the separation device in a sterile condition as the composition is introduced, the conduit is movable to selectively engage and disengage the separation device without removing the cover.
US Referenced Citations (215)
Number Name Date Kind
1378806 Ausubel May 1921 A
1948388 Liberson Feb 1934 A
1950137 Dowe Mar 1934 A
2112160 Johnson Mar 1938 A
2322753 Thomas Jun 1943 A
2533004 Ferry et al. Dec 1950 A
2915063 Cutter Dec 1959 A
RE25113 Wilburn Jan 1962 E
3112747 Cowley Dec 1963 A
3215141 Podhora Nov 1965 A
3223083 Cobey Dec 1965 A
3236418 Dalle et al. Feb 1966 A
3314427 Stafford Apr 1967 A
3406686 Keller Oct 1968 A
3435944 Ishii Apr 1969 A
3467096 Horn Sep 1969 A
3473646 Burke Oct 1969 A
3552394 Horn Jan 1971 A
3586064 Brown et al. Jun 1971 A
3625353 Ishii Dec 1971 A
3654925 Holderith Apr 1972 A
3685248 Godelaine Aug 1972 A
3767085 Cannon et al. Oct 1973 A
3780935 Lukacs et al. Dec 1973 A
3800947 Smith Apr 1974 A
3828980 Creighton et al. Aug 1974 A
3894952 Ayres Jul 1975 A
3937219 Karakashian Feb 1976 A
3976073 Quick et al. Aug 1976 A
4021352 Sarstedt et al. May 1977 A
4040420 Speer Aug 1977 A
4057499 Buono Nov 1977 A
4121739 Devaney et al. Oct 1978 A
4142668 Lee Mar 1979 A
4184593 Dorr et al. Jan 1980 A
4202769 Greenspan May 1980 A
4226235 Sarnoff et al. Oct 1980 A
4260077 Schroeder Apr 1981 A
4269174 Adair May 1981 A
4322298 Persidsky Mar 1982 A
4359049 Redl et al. Nov 1982 A
4375272 Sutton, III Mar 1983 A
4413773 Rohde et al. Nov 1983 A
4424132 Iriguchi et al. Jan 1984 A
4434820 Glass Mar 1984 A
4465476 Gahwiler et al. Aug 1984 A
4467588 Carveth Aug 1984 A
4498904 Turner et al. Feb 1985 A
4524770 Orandi Jun 1985 A
4610666 Pizzino Sep 1986 A
4627879 Rose et al. Dec 1986 A
4628969 Jurgens, Jr. et al. Dec 1986 A
4631055 Redl et al. Dec 1986 A
4650468 Jennings, Jr. Mar 1987 A
4673395 Phillips et al. Jun 1987 A
4714457 Alterbaum Dec 1987 A
4734261 Koizumi et al. Mar 1988 A
4735616 Eibl et al. Apr 1988 A
4744955 Shapiro May 1988 A
4767026 Keller et al. Aug 1988 A
4818386 Burns Apr 1989 A
4822340 Kamstra et al. Apr 1989 A
4826048 Skorka et al. May 1989 A
4828716 McEwen et al. May 1989 A
4874368 Miller et al. Oct 1989 A
4877520 Burns Oct 1989 A
4878903 Mueller Nov 1989 A
4902281 Avoy Feb 1990 A
4907019 Stephens Mar 1990 A
4932942 Maslanka et al. Jun 1990 A
4957637 Cornell Sep 1990 A
4978336 Capozzi et al. Dec 1990 A
4979942 Wolf et al. Dec 1990 A
5032117 Motta Jul 1991 A
5033252 Carter Jul 1991 A
5049135 Davis Sep 1991 A
5074844 Zdeb et al. Dec 1991 A
5080262 Herold et al. Jan 1992 A
5104375 Wolf et al. Apr 1992 A
5104387 Pokorney et al. Apr 1992 A
5116315 Capozzi et al. May 1992 A
5147323 Haber et al. Sep 1992 A
5152905 Pall et al. Oct 1992 A
5160021 Sibley et al. Nov 1992 A
5176658 Ranford Jan 1993 A
5217118 Mochizuki et al. Jun 1993 A
5226558 Whitney et al. Jul 1993 A
5226877 Epstein Jul 1993 A
5226887 Farr et al. Jul 1993 A
5253785 Haber et al. Oct 1993 A
5286257 Fischer Feb 1994 A
5290259 Fischer Mar 1994 A
5292318 Haber et al. Mar 1994 A
5298024 Richmond Mar 1994 A
5300041 Haber et al. Apr 1994 A
5308041 Griffioen et al. May 1994 A
5314412 Rex et al. May 1994 A
5318524 Morse et al. Jun 1994 A
5322510 Lindner et al. Jun 1994 A
5332092 Fischer Jul 1994 A
5354483 Furse Oct 1994 A
5361906 Sterett Nov 1994 A
5368563 Lonneman et al. Nov 1994 A
5372586 Haber et al. Dec 1994 A
5376079 Holm et al. Dec 1994 A
5390792 Van Ness et al. Feb 1995 A
5393497 Haber et al. Feb 1995 A
5393674 Levine et al. Feb 1995 A
5409465 Boggs et al. Apr 1995 A
5411465 Glen et al. May 1995 A
5419491 Breitsprecher May 1995 A
5420250 Lontz May 1995 A
5445614 Haber et al. Aug 1995 A
5454793 Levander et al. Oct 1995 A
5464396 Barta et al. Nov 1995 A
5474540 Miller et al. Dec 1995 A
5478323 Westwood et al. Dec 1995 A
5480068 Frazier et al. Jan 1996 A
5484431 Scharf et al. Jan 1996 A
5505704 Pawelka et al. Apr 1996 A
5510102 Cochrum Apr 1996 A
5519422 Thoman et al. May 1996 A
5519931 Reich May 1996 A
5520657 Sellers et al. May 1996 A
5520658 Holm et al. May 1996 A
5522804 Lynn Jun 1996 A
5530531 Girard Jun 1996 A
5542934 Silver Aug 1996 A
5549651 Lynn Aug 1996 A
5582596 Fukunaga et al. Dec 1996 A
5585007 Antanavich et al. Dec 1996 A
5597530 Smith et al. Jan 1997 A
5605255 Reidel et al. Feb 1997 A
5605541 Holm Feb 1997 A
5638661 Banks Jun 1997 A
5643206 Fischer Jul 1997 A
5656035 Avoy Aug 1997 A
5665067 Linder et al. Sep 1997 A
5697915 Lynn Dec 1997 A
5728075 Levander et al. Mar 1998 A
5752626 Bachand May 1998 A
5759169 Marx Jun 1998 A
5759171 Coelho et al. Jun 1998 A
5792103 Schwartz et al. Aug 1998 A
5810885 Zinger et al. Sep 1998 A
5814022 Antanavich et al. Sep 1998 A
5814066 Spotnitz Sep 1998 A
5819988 Sawhney et al. Oct 1998 A
5824012 Burchett et al. Oct 1998 A
5830547 MacKenzie et al. Nov 1998 A
5842326 Wolf Dec 1998 A
5871700 Konrad Feb 1999 A
5881536 Muller-Wille et al. Mar 1999 A
5888408 Nagels Mar 1999 A
5935437 Whitmore Aug 1999 A
5951517 Lampropoulos et al. Sep 1999 A
5968018 Freeman et al. Oct 1999 A
5976102 Epstein Nov 1999 A
5980866 Uchida et al. Nov 1999 A
5997811 Esposito Dec 1999 A
5997881 Powell et al. Dec 1999 A
6001259 Whitmore Dec 1999 A
6059749 Marx May 2000 A
6063055 Epstein et al. May 2000 A
6079868 Rydell Jun 2000 A
6099511 Devos et al. Aug 2000 A
6113571 Zinger et al. Sep 2000 A
6123687 Simonyi et al. Sep 2000 A
6132396 Antanavich et al. Oct 2000 A
6206905 Holm et al. Mar 2001 B1
6234994 Zinger et al. May 2001 B1
6251370 Uchida et al. Jun 2001 B1
6308747 Farris Oct 2001 B1
6328229 Duronio et al. Dec 2001 B1
6331172 Epstein et al. Dec 2001 B1
6394982 Ehrenfels May 2002 B1
6471670 Enrenfels et al. Oct 2002 B1
6475193 Park et al. Nov 2002 B1
6488650 Epstein et al. Dec 2002 B1
6544162 Van Wie et al. Apr 2003 B1
6648133 Blaschke et al. Nov 2003 B1
6711879 Korteweg et al. Mar 2004 B2
6830762 Baugh et al. Dec 2004 B2
6959812 Reif et al. Nov 2005 B2
7179391 Leach et al. Feb 2007 B2
7223346 Dorian et al. May 2007 B2
7374678 Leach et al. May 2008 B2
7470371 Dorian et al. Dec 2008 B2
7766900 Leach et al. Aug 2010 B2
20010016709 Tovey et al. Aug 2001 A1
20020035820 Farris Mar 2002 A1
20020104808 Blasetti et al. Aug 2002 A1
20030023203 Lavi et al. Jan 2003 A1
20030029763 Reif et al. Feb 2003 A1
20030139774 Epstein et al. Jul 2003 A1
20040024353 Petersen et al. Feb 2004 A1
20040035743 Tighe et al. Feb 2004 A1
20040065626 Woo Apr 2004 A1
20040209755 Moore et al. Oct 2004 A1
20050247715 Ellsworth et al. Nov 2005 A1
20060064070 Martin Mar 2006 A1
20060175242 Dorian et al. Aug 2006 A1
20060196885 Leach et al. Sep 2006 A1
20060217674 Romano et al. Sep 2006 A1
20060273049 Leach et al. Dec 2006 A1
20060273050 Higgins et al. Dec 2006 A1
20060278588 Woodell-May Dec 2006 A1
20070012623 Robinson et al. Jan 2007 A1
20080217264 Leach et al. Sep 2008 A1
20080217265 Leach et al. Sep 2008 A1
20080283474 Leach et al. Nov 2008 A1
20090014391 Leach et al. Jan 2009 A1
20090221075 Dorian et al. Sep 2009 A1
20090253566 Chavarria Oct 2009 A1
20100274206 Leach et al. Oct 2010 A1
Foreign Referenced Citations (41)
Number Date Country
2244697 Aug 1997 CA
2295733 Jan 1999 CA
632579 Sep 1936 DE
807113 Jun 1951 DE
3246999 May 1984 DE
8913761 Mar 1990 DE
29516650 Jan 1996 DE
0208053 Jan 1987 EP
0253418 Jan 1988 EP
0253949 Jan 1988 EP
0292472 Nov 1988 EP
0316284 May 1989 EP
0432871 Jun 1991 EP
0528949 Mar 1993 EP
592242 Apr 1994 EP
0858776 Aug 1998 EP
840257 Apr 1939 FR
2612782 Sep 1988 FR
2661097 Oct 1991 FR
2666986 Mar 1992 FR
2668060 Apr 1992 FR
08238314 Sep 1996 JP
08280802 Oct 1996 JP
09108302 Apr 1997 JP
WO-8807874 Oct 1988 WO
WO-9001959 Mar 1990 WO
WO-9101711 Feb 1991 WO
WO-9117778 Nov 1991 WO
WO-9419038 Sep 1994 WO
WO-9639212 Dec 1996 WO
WO-9725015 Jul 1997 WO
WO-9728834 Aug 1997 WO
WO-9746203 Dec 1997 WO
WO-9747343 Dec 1997 WO
WO-9802098 Jan 1998 WO
WO-9810703 Mar 1998 WO
WO-9810704 Mar 1998 WO
WO-9813094 Apr 1998 WO
WO-9840115 Sep 1998 WO
WO-9901069 Jan 1999 WO
WO-03018425 Mar 2003 WO
Non-Patent Literature Citations (24)
Entry
“The New Gold Standard” brochure for GPS® Mini and GPS®II Platelet Concentrate Separation Kit with ACD-A Anticoagulant, Biomet Biologics, Inc. (Dec. 2006), 7 pages.
International Search Report mailed Jul. 10, 2009 for PCT/US2009/039488 claiming benefit of U.S. Appl. No. 12/062,817, filed Apr. 4, 2008.
International Preliminary Examination Report issued Oct. 5, 2010 for PCT/US2009/039488 claiming benefit of U.S. Appl. No. 12/062,817, filed Apr. 4, 2008.
Alving, B.M., M.J. Weinstein, et al. (1995). “Fibrin sealant: summary of a conference on characteristics and clinical uses.” Transfusion 35(9): 783-90.
B. Braun/McGaw Product Catalog, May 1, 1999.
CFT Cell Factor Technologies, Inc., GPS® II Platelet Concentrate System, 2004 Biomet Orthopedics, Inc. (10 pages).
DePuy AcroMed, Inc., Symphony™ Platelet Concentrate System, 2001.
Developing Technologies for Accelerating Healing, Naturally®, Smart PReP®2, Harvest® Technologies Corp. 2002 (6 pages).
Drug Intelligence and Clinical Pharmacy, vol. 22, pp. 946-952, Dec. 1988, Dennis F. Thompson, et al., “Fibrin Glue: A Review of Its Preparation, Efficacy, and Adverse Effects as a Topical Hemostat”.
DynaStat™, Introducing DynaStat™Surgical Hemostat—An Innovation in Hemostatic Biodevices, 2000 Cohesion Technologies, Inc.
FibriJet® 11:1 Ratio Applicator, Micromedics, Inc., printed from www.micromedics-usa.com/products/PDFs/FibriJet—Easy-Assembly.pdf, in 2005 (1 page).
FibriJet® product sheet, Micromedics, Inc., printed from www.micromedics-usa.com/products/PDFs/product—sheet.pdf, in 2005 (2 pages).
FibriJet®Ratio Applicator for application of platelet gel, Micromedics, Inc., printed from www.micromedics-usa.com/products/PDFs/ratio.pdf, in 2005 (1 page).
Matras, H. (1985). “Fibrin seal: the state of the art.” J Oral Maxillofac Surg 43(8): 605-11.
Matras, Helene, H. P. Dinges, H. Lassmann, and B. Mamoli. “Zur nahtlosen interfaszikularen Nerventransplantation im Tierexperiment.” Wein Med Woschtr 122 (37 1972): 517-523.
OEM Products Catalog, Merit®Medical, available by Jan. 2003.
Prof. H. Stütz, M.D., et al., The Use of Autologous Fibrin Glue to Reduce Perioperative Blood Loss in Total Knee Arthroplasty—Results of a Controlled Study, Translated from the original article published in Orthopädische Praxis 40, 12 (2004).
Redl, H. and G. Schlag (1986). Fibrin Sealant and Its Modes of Application. Fibrin Sealant in Operative Medicine. G. Schlad and H. Redl. Heidelberg, Springer-Verlag: 13-26.
Redl, H.G. Schlag, et al. (1982). “Methods of Fibrin Seal Application.” Thorac, cardiovasc. Surgeon 30: 223-227.
Shimada, J.K. Mikami, et al. (1995). “Closure of leaks by fibrin gluing. Effects of various application techniques and temperatures.” J Cardiovac Surg (Torino) 35(2): 181-4.
Sierra, D. H. “Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications.” J Biomater Appl 7 (4 1993): 309-52.
Sporn, L.A., et al., (1995). “Cell proliferation on fibrin: modulation by fibrinopeptide cleavage.” Blood 86(5): 1802-10.
Tange, R.A. (1986). “A New Application Method for Fibrin Sealant: The Glue Gun.” Fibrin Sealant in Operative Medicine. G. Schlad and H. Redl. Heidelberg, Springer-Verlag.
Vox Sanq, vol. 68: 82-89, Feb. 1995, Boomgaard et. al, Pooled Platelet Concentrates Prepared by the Platelet-Rich-Plasma Method and Filtered with Three Different Filters and Stored for 8 Days.
Related Publications (1)
Number Date Country
20090250413 A1 Oct 2009 US